BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35449832)

  • 21. Diagnostic Value of Contrast-Enhanced Spectral Mammography in Comparison to Magnetic Resonance Imaging in Breast Lesions.
    Xing D; Lv Y; Sun B; Xie H; Dong J; Hao C; Chen Q; Chi X
    J Comput Assist Tomogr; 2019; 43(2):245-251. PubMed ID: 30531546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR-Guided Near-Infrared Spectral Tomography Increases Diagnostic Performance of Breast MRI.
    Mastanduno MA; Xu J; El-Ghussein F; Jiang S; Yin H; Zhao Y; Wang K; Ren F; Gui J; Pogue BW; Paulsen KD
    Clin Cancer Res; 2015 Sep; 21(17):3906-12. PubMed ID: 26019171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast DCE-MRI: influence of postcontrast timing on automated lesion kinetics assessments and discrimination of benign and malignant lesions.
    Partridge SC; Stone KM; Strigel RM; DeMartini WB; Peacock S; Lehman CD
    Acad Radiol; 2014 Sep; 21(9):1195-203. PubMed ID: 24998690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic contrast enhanced MRI breast for lesion detection and characterization with histopathological co relation: preliminary experience at tertiary care hospital.
    Shafqat G; Agha A; Masror I; Rehan M; Afzal S
    J Pak Med Assoc; 2011 Mar; 61(3):252-5. PubMed ID: 21465939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer.
    Wang W; Lv S; Xun J; Wang L; Zhao F; Wang J; Zhou Z; Chen Y; Sun Z; Zhu L
    Eur J Radiol; 2022 Sep; 154():110392. PubMed ID: 35679701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of spatiotemporal changes for the classification of dynamic contrast-enhanced magnetic-resonance breast lesions.
    Milenković J; Hertl K; Košir A; Zibert J; Tasič JF
    Artif Intell Med; 2013 Jun; 58(2):101-14. PubMed ID: 23548472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
    Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
    AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation of breast cancer from fibroadenoma with dual-echo dynamic contrast-enhanced MRI.
    Wang S; Delproposto Z; Wang H; Ding X; Ji C; Wang B; Xu M
    PLoS One; 2013; 8(7):e67731. PubMed ID: 23844077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
    Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
    J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of diffuse optical tomography, ultrasound elastography and mammography in the diagnosis of breast tumors.
    Zhang H; Qin D; Yang Z; Wang K; Sun F; Li B; Cui G
    Ultrasound Med Biol; 2014 Jan; 40(1):1-10. PubMed ID: 24210860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
    Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
    Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The value of synthetic MRI in differential diagnosis of benign and malignant breast lesions].
    Che SN; Li J; Xue M; Song Y; Zhao LY; Guo N; Tian Y; Xie LZ; Zhao XM; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):872-877. PubMed ID: 34407594
    [No Abstract]   [Full Text] [Related]  

  • 34. Preoperative predicting malignancy in breast mass-like lesions: value of adding histogram analysis of apparent diffusion coefficient maps to dynamic contrast-enhanced magnetic resonance imaging for improving confidence level.
    Liu HL; Zong M; Wei H; Lou JJ; Wang SQ; Zou QG; Shi HB; Jiang YN
    Br J Radiol; 2017 Nov; 90(1079):20170394. PubMed ID: 28876982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Separation of benign and malignant breast lesions using dynamic contrast enhanced MRI in a biopsy cohort.
    Kim SG; Freed M; Leite APK; Zhang J; Seuss C; Moy L
    J Magn Reson Imaging; 2017 May; 45(5):1385-1393. PubMed ID: 27766710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging.
    Min Q; Shao K; Zhai L; Liu W; Zhu C; Yuan L; Yang J
    World J Surg Oncol; 2015 Feb; 13():32. PubMed ID: 25889380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Combined Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MRI for Differentiating Malignant From Benign Breast Lesions Presenting Washout Curve.
    Tezcan S; Ozturk FU; Uslu N; Akcay EY
    Can Assoc Radiol J; 2021 Aug; 72(3):460-469. PubMed ID: 32157892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
    Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
    Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.